The findings of the report shows that there is a beneficial role of using inhaled nitric oxide to improve respiratory parameters, but that it does not translate to a mortality benefit. It adds to the investigation of establishing which patients, the duration and at what dose, inhaled nitric oxide should be used to gain maximum benefit for this subgroup of patients.
Keyphrases
- nitric oxide
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- cystic fibrosis
- prognostic factors
- intensive care unit
- hydrogen peroxide
- clinical trial
- randomized controlled trial
- nitric oxide synthase
- coronary artery disease
- cardiovascular disease
- coronary artery
- pulmonary artery
- acute respiratory distress syndrome
- study protocol
- open label
- extracorporeal membrane oxygenation